GlassScriptPhysician profile
Randy Michael Brodnik
NPI 1609861996
$1,637.16
in general payments reported to CMS, 2019-2025
21 companies · $425 in 2025
The $425 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $333 · 2021: $221 · 2022: $306 · 2023: $170 · 2024: $16.22 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $593.42 | 2019-2025 | |
| Axonics, INC. | $406.55 | 2020-2023 | Axonics |
| Therapeuticsmd, INC. | $118.32 | 2019-2022 | |
| Hologic Sales and Service, LLC | $94.53 | 2021-2022 | |
| Lupin INC. | $57.71 | 2020 | |
| Astellas Pharma US INC | $54.70 | 2023 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.23 | 2025 | Jardiance |
| Lilly USA, LLC | $33.73 | 2025 | Mounjaro, Zepbound |
| Medtronic, INC. | $30.17 | 2022 | |
| Intuitive Surgical, INC. | $28.62 | 2021 | |
| Organon LLC | $27.76 | 2023 | Nexplanon |
| Novo Nordisk INC | $21.01 | 2025 | Rybelsus, Ozempic |
| Myovant Sciences INC. | $19.14 | 2022 | |
| Avanos Medical | $17.72 | 2023 | On-Q* Pump and Accessories |
| Bayer Healthcare Pharmaceuticals INC. | $16.22 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.24 | 2021 | |
| Exeltis, USA INC. | $14.79 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.45 | 2025 | Airsupra |
| Glaxosmithkline, LLC. | $14.15 | 2025 | Trelegy Ellipta |
| Amgen INC. | $13.64 | 2025 | Prolia, Evenity |
| Duchesnay USA Incorporated | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Brodnik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.